Clinical Value of Pentraxin-3, Heparin Binding Protein and C-Reactive Protein In Interstitial Lung Diseases - Amsterdam 2025

Translational studies in interstitial lung disease of known causes

Chair(s): Thomas Planté-Bordeneuve, Laurens De Sadeleer

Session type: Poster session

Clinical Value of Pentraxin-3, Heparin Binding Protein and C-Reactive Protein In Interstitial Lung Diseases

Ceren Gokce Coskun Ekiz

EVENTS HOME

Abstract

Previous presentation

Next presentation

Session content

Artificial Intelligence-analyzed airway parameters and disease progression in fibrotic Hypersensitivity Pneumonitis

Giulia Lunati

Poster

Abstract

Impact of epicardial adipose tissue on comorbidities and prognosis in fibrotic interstitial lung disease

Raphaël Hindré

Poster

Abstract

Comparative proteomic insights in idiopathic and post-COVID pulmonary fibrosis

Suniti Yadav

Poster

Abstract

Integrated plasma proteomic drives Risk stratification and phenotypic trajectory in ILD

Junfeng Huang

Poster

Abstract

Cytokine biomarkers and machine learning for disease staging in artificial stone silicosis

Antonio Campos-caro

Poster

Abstract

Mesenchymal stromal cell priming in the treatment of systemic sclerosis

Sydney Joy

Poster

Abstract

Comparison of Quantitative Image Analysis and visual change assessment methods in interstitial lung disease progression

Wieying Kuo

Poster

Abstract

GM-CSF-treated bone marrow-derived macrophages improve pulmonary fibrosis in bleomycin-treated mice

Sydney Joy

Poster

Abstract

Impulse Oscillometry in Avian Fibrotic Hypersensitivity Pneumonitis a prospective study

Ana Filipa Soares Correia

Poster

Abstract

Clinical Value of Pentraxin-3, Heparin Binding Protein and C-Reactive Protein In Interstitial Lung Diseases

Ceren Gokce Coskun Ekiz

Abstract

Seralutinib shows significant anti-fibrotic effects: Evidence from patient-derived models

Ravikumar Sitapara

Poster

Abstract

Characterizing the antifibrotic activity of bexotegrast on pathologic cell populations in multiple ILD subtypes

Eric Lefebvre

Poster

Abstract

Plasma biomarkers for diagnosis and prognosis in interstitial lung disease (ILD)

Karin Von Wachenfeldt

Poster

Abstract

Evaluation of the antifibrotic effect of a dual ?v?6/?v?1 integrin inhibitor in a mouse model of rheumatoid arthritis-associated interstitial lung disease

Eric Lefebvre

Poster

Abstract

Predictive Power of the e-Lung Weighted Reticulovascular Score for Mortality in Progressive Pulmonary Fibrosis

Ayodeji Adegunsoye

Poster

Abstract

Pulmonary function and proteolytic activity of blood in patients with systemic scleroderma.

Oksana Karasova

Poster

Abstract

Multi-Omics Reveals Gut-Lung Axis Dysbiosis and Metabolic Shifts in Pulmonary Fibrosis

Jing Gao

Poster

Abstract

Investigating the effect of transforming growth factor (TGF)-? isoforms 1, 2, and 3 on lung and dermal fibroblast functions

Raveen Badyal

Poster

Abstract

Novel autoantibody profiles in primary Sjögrens disease with Interstitial Lung Disease

Jan Christoph Gras

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}